Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH   3:59:53 PM EDT
6.68
+0.17 (+2.61%)
Earnings Announcements

Cyclo Therapeutics Qtrly Loss Per Share 56 Cents

Published: 08/17/2021 13:13 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results.
Cyclo Therapeutics, Inc - Qtrly Loss per Share 56 Cents.
Revenue is expected to be $0.38 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $0.39 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.